Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-058413

Chief Finance & Strat Officer sold 1,388 shares at $13.51 ($18,752)

  • Chief Finance & Strat Officer acquired 5,237 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward Chief Finance & Strat Officer 2025-12-19 Option exercise +5,237 128,218 D
Stelmakh Edward Chief Finance & Strat Officer 2025-12-19 Sale −1,388 $13.51 $18,752 126,830 D
Derivatives
Stelmakh Edward Chief Finance & Strat Officer 2025-12-19 Option exercise · Restricted Stock Units −5,237 5,237 D
Open-market sales · 1,388 sh · avg $13.51 · $18,752
Loading xslF345X05/wk-form4_1766416244.xml…